SCHEMBL26378512

SCHEMBL26378512

CN(C)C(CS)C(=O)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26378518 0.79 PRKCA (0.31) —
SCHEMBL24069465 0.79 USP2 (0.30) —
SCHEMBL18135528 0.77 — —
SCHEMBL197122 0.73 — —
SCHEMBL8721546 0.73 — —
SCHEMBL13542888 0.73 — —
SCHEMBL197121 0.73 — —
SCHEMBL15336525 0.73 — —
SCHEMBL30207652 0.72 LMNA (0.30) —
Hydrochloric Acid SCHEMBL9807456 0.71 PTGS1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312591-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF TENACIA BIOTECHNOLOGY (HONG KONG) CO., LIMITED (HK) 2023-10-05 — — US disclosed
US-20230131402-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF APTINYX INC (US) 2023-04-27 — — US disclosed
Send feedback